ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.5262
-0.0138 (-2.56%)
At close: Jul 25, 2025, 4:00 PM
0.5300
+0.0038 (0.72%)
After-hours: Jul 25, 2025, 7:19 PM EDT

ALX Oncology Holdings Stock Forecast

ALXO's stock price has decreased by -91.53% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 6 analysts that cover ALX Oncology Holdings stock have a consensus rating of "Strong Buy" and an average price target of $3.3, which forecasts a 527.14% increase in the stock price over the next year. The lowest target is $1 and the highest is $9.

Price Target: $3.3 (+527.14%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$1.00$3.30$2.00$9.00
Change+90.04%+527.14%+280.08%+1610.4%
* Price targets were last updated on May 21, 2025.

Analyst Ratings

The average analyst rating for ALX Oncology Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy233333
Buy222222
Hold211111
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Strong Buy
Maintains
$1.2$1
Strong BuyMaintains$1.2$1+90.04%May 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$5$2
Strong BuyMaintains$5$2+280.08%May 9, 2025
Stifel
Stifel
Hold
Maintains
$3$1.5
HoldMaintains$3$1.5+185.06%Mar 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong BuyReiterates$5+850.21%Mar 7, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$8$9
BuyMaintains$8$9+1,610.38%Mar 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.82
from -2.58
EPS Next Year
-1.29
from -1.82
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
1.18M-------
Revenue Growth
-75.35%-------
EPS
-2.76-2.07-3.03-3.74-2.58-1.82-1.29-0.94
EPS Growth
--------
Forward PE
--------
No. Analysts
-----776
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/an/a
Avgn/an/an/a
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS202520262027
High-1.56-0.82-0.46
Avg-1.82-1.29-0.94
Low-1.99-1.70-1.55

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.